Peter D'Arrigo

Statistics

Publications

Citations

264

H-Index

Active since

1984

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

University of Chicago

University of Rochester

SUNY Upstate Medical University

Emory University

Peter D'Arrigo is an author at Roswell Park Comprehensive Cancer Center specializing in chemotherapy, chemotherapy in hematologic malignancies, and medicine.

Publications per year

1984–1989

Publications

High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study.

Harvey D. Preisler, Abbas Raza, Maurice Barcos et al. · Journal of Clinical Oncology · 1987 · 79 citations

Medicine, Hematology, Oncology +15

Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia

HarveyD. Preisler, Teresa Gessner, N. Azarnia et al. · Cancer Chemotherapy and Pharmacology · 1984 · 62 citations

Medicine, Oncology, Pharmacotherapy +13

Prediction of response of acute nonlymphocytic leukaemia to therapy with ‘high dose’ cytosine arabinoside

Harvey D. Preisler, Joshua Epstein, Maurice Barcos et al. · British Journal of Haematology · 1984 · 54 citations

Medicine, Hematology, Pharmacotherapy +17

High‐dose cytosine arabinoside in the treatment of preleukemic disorders: A leukemia intergroup study

Harvey D. Preisler, Azra Raza, Maurice Barcos et al. · American Journal of Hematology · 1986 · 42 citations

Medicine, Hematology, Pharmacology +15

Use of the day 6 bone marrow to alter remission induction therapy in patients with acute myeloid leukaemia: a leukemia intergroup study

George P. Browman, Harvey D. Preisler, Ali Raza et al. · British Journal of Haematology · 1989 · 27 citations

Medicine, Hematology, Oncology +14

1–5 of 5